- Opportunity and Forecast, 2016 - 2025
Stem cell therapy is the use of stem cells for treatment or prevention of diseases. Research activities are conducted worldwide for development of stem cell treatments for heart diseases, diabetes, and others. It is majorly used for the treatment of cancer, to study effects on neuronal degeneration, multiple sclerosis, spinal cord injury, and others. Ongoing R&D activities and novel techniques are expected to foster the growth of the market in the coming years.
Rise in funding, development of advanced genomic methods, increase in focus on human embryonic stem cells, and surge in approvals of clinical trials for stem cells therapy drive the growth of the global stem cell therapy market. However, lack of required infrastructure, difficulties related with the preservation of stem cells, ethical issues, immunorejection after stem cell transplantation, complexity involved in identification of stem cells in adult tissues limit the market growth. Lack of effective treatments to cure diseases, evolution of new stem cell therapies, and emergence of induced pluripotent stem (IPS) cells as an alternative to ESCS are anticipated to create opportunities in the industry.
The global stem cell therapy market is segmented based on mode of therapy, therapeutic applications, and geography. Mode of therapy is subsegmented into allogeneic and autologous stem cell therapy. On the basis of therapeutic applications, the market is divided into eye diseases, GIT diseases, metabolic diseases, immune system diseases, musculoskeletal disorders, CNS diseases, wounds & injuries, and others. Geographically, the market is segmented into North America, Asia-Pacific, Europe, and LAMEA.
Key players profiled in the report are Aastrom Biosciences Inc., Advanced Cell Technologies, Inc., Athersys Inc., Celgene Corporation, Cellular Dynamics International, Cytori Therapeutics, Inc., Fibrocell Science, Inc., and others. They have adopted various strategies, such as mergers & acquisition, expansions, new product launches, joint ventures, collaborations, partnerships, and others to strengthen their foothold in the global market.
Please Select Format
Need More Information
Why Progressive Markets
The market research services provided by Progressive Markets are restricted to publications, which may also include insignificant market data. The services are for the internal use of customers only and they do not have any rights to utilize this data for general publications or/and disclosure to third parties. As data is gathered through research activities such as online surveys and interviews with industry experts, it may have variations and fluctuation due to constantly changing market conditions. Thus, Progressive Markets holds no responsibility for misleading or false information gathered from these sources.
Progressive Markets understands and respects the privacy of persona
Recently Viewed Reports
The global silver consumption accounted for 37,704 tons in 2016 and expected to reach 49,860 tons by 2022, growing at a CAGR of 4.6% from 2017 to 2022. Silver is ... Read More >>